Truist Financial’s Thermo Fisher Scientific TMO Stock Holding History

Truist Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.3M	Sell	112,556 -1,615	-1%	-$876K	0.07%	223
2025 Q4	$66.2M	Sell	114,171 -3,266	-3%	-$1.85M	0.09%	198
2025 Q3	$57M	Sell	117,437 -10,830	-8%	-$5.04M	0.08%	219
2025 Q2	$52M	Sell	128,267 -1,962	-2%	-$820K	0.08%	230
2025 Q1	$64.8M	Sell	130,229 -6,419	-5%	-$3.48M	0.1%	182
2024 Q4	$71.1M	Sell	136,648 -4,813	-3%	-$2.65M	0.11%	173
2024 Q3	$87.5M	Sell	141,461 -7,524	-5%	-$4.45M	0.14%	144
2024 Q2	$82.4M	Sell	148,985 -3,857	-3%	-$2.21M	0.13%	162
2024 Q1	$88.8M	Sell	152,842 -4,472	-3%	-$2.51M	0.13%	150
2023 Q4	$83.5M	Sell	157,314 -36,454	-19%	-$17.6M	0.13%	152
2023 Q3	$98.1M	Sell	193,768 -33,431	-15%	-$17.8M	0.16%	129
2023 Q2	$119M	Buy	227,199 +1,251	+0.6%	+$675K	0.2%	115
2023 Q1	$130M	Sell	225,948 -8,342	-4%	-$4.7M	0.22%	106
2022 Q4	$129M	Buy	234,290 +1,871	+0.8%	+$991K	0.23%	111
2022 Q3	$118M	Buy	232,419 +2,238	+1%	+$1.25M	0.23%	103
2022 Q2	$125M	Sell	230,181 -1,034	-0.4%	-$569K	0.23%	102
2022 Q1	$137M	Sell	231,215 -9,763	-4%	-$5.61M	0.22%	114
2021 Q4	$161M	Buy	240,978 +10,361	+4%	+$6.47M	0.25%	95
2021 Q3	$132M	Buy	230,617 +4,123	+2%	+$2.26M	0.22%	112
2021 Q2	$114M	Sell	226,494 -7,981	-3%	-$3.77M	0.19%	130
2021 Q1	$107M	Buy	234,475 +21,029	+10%	+$10M	0.19%	132
2020 Q4	$99.4M	Buy	213,446 +20,153	+10%	+$9.45M	0.19%	118
2020 Q3	$85.3M	Sell	193,293 -33,635	-15%	-$13.9M	0.19%	131
2020 Q2	$82.2M	Buy	226,928 +9,531	+4%	+$3.19M	0.18%	135
2020 Q1	$61.7M	Buy	217,397 +2,954	+1%	+$931K	0.16%	143
2019 Q4	$69.7M	Buy	214,443 +190,791	+807%	+$57.9M	0.14%	157
2019 Q3	$6.89M	Buy	23,652 +6,094	+35%	+$1.75M	0.12%	184
2019 Q2	$5.16M	Buy	17,558 +9,911	+130%	+$2.73M	0.09%	219
2019 Q1	$2.09M	Buy	7,647 +264	+4%	+$65.7K	0.04%	345
2018 Q4	$1.65M	Buy	7,383 +2,130	+41%	+$500K	0.03%	363
2018 Q3	$1.28M	Buy	5,253 +1,560	+42%	+$359K	0.02%	432
2018 Q2	$765K	Buy	3,693 +6	+0.2%	+$1.27K	0.01%	515
2018 Q1	$761K	Sell	3,687 -360	-9%	-$75.6K	0.01%	507
2017 Q4	$768K	Sell	4,047 -417	-9%	-$79.9K	0.01%	517
2017 Q3	$845K	Buy	4,464 +5	+0.1%	+$906	0.02%	494
2017 Q2	$778K	Sell	4,459 -1,928	-30%	-$324K	0.02%	503
2017 Q1	$981K	Sell	6,387 -5,941	-48%	-$908K	0.02%	471
2016 Q4	$1.74M	Sell	12,328 -973	-7%	-$143K	0.04%	385
2016 Q3	$2.12M	Sell	13,301 -325	-2%	-$50.1K	0.04%	361
2016 Q2	$2.01M	Buy	13,626 +1,191	+10%	+$176K	0.04%	365
2016 Q1	$1.76M	Buy	12,435 +797	+7%	+$107K	0.05%	334
2015 Q4	$1.65M	Sell	11,638 -2,099	-15%	-$280K	0.04%	342
2015 Q3	$1.68M	Buy	13,737 +666	+5%	+$86.8K	0.04%	339
2015 Q2	$1.7M	Sell	13,071 -763	-6%	-$99.5K	0.05%	314
2015 Q1	$1.86M	Buy	13,834 +906	+7%	+$117K	0.05%	288
2014 Q4	$1.62M	Buy	12,928 +2,419	+23%	+$294K	0.05%	307
2014 Q3	$1.28M	Buy	10,509 +857	+9%	+$104K	0.04%	344
2014 Q2	$1.14M	Buy	9,652 +91	+1%	+$10.7K	0.03%	359
2014 Q1	$1.15M	Buy	9,561 +537	+6%	+$63.8K	0.04%	351
2013 Q4	$1M	Sell	9,024 -237	-3%	-$23.6K	0.03%	368
2013 Q3	$854K	Buy	9,261 +120	+1%	+$10.9K	0.03%	370
2013 Q2	$774K	Buy	+9,141	New	+$761K	0.03%	376

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Truist Financial's TMO Position: Q1 2026 in Review

Truist Financial reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q1 2026, selling an estimated $876K and leaving 112,556 shares worth $55.3M. The position accounts for 0.07% of the portfolio, ranked #223.

Truist Financial first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Truist Financial held 112,556 shares of Thermo Fisher Scientific worth $55.3M as of Q1 2026.
Truist Financial sold 1,615 Thermo Fisher Scientific shares in Q1 2026, an estimated $876K.
Thermo Fisher Scientific made up 0.07% of Truist Financial's portfolio in Q1 2026, its #223 holding.
Truist Financial first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Truist Financial's Thermo Fisher Scientific position peaked at $161M in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.